GLP-1 Market to Reach $180 Billion by 2035 at 8.7% CAGR | Novo Nordisk, Eli Lilly, Pfizer Among Key Players

AI Briefing

• – The global GLP-1 market is expected to reach $180 billion by 2035 at a 8.7% CAGR.
• – Novo Nordisk, Eli Lilly, and Pfizer are among the key players in the market.
• – Type 2 diabetes is the primary driver of the growing demand for GLP-1 therapies.